The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CLPT | +37.28% | +75.94% | +11.95% | -49% |
| S&P | +13.19% | +87.83% | +13.42% | +412% |
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
No news articles found for ClearPoint Neuro.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $8.86M | 9.1% |
| Gross Profit | $5.60M | 15.5% |
| Gross Margin | 63.20% | 3.5% |
| Market Cap | $619.43M | 100.2% |
| Market Cap / Employee | $5.39M | 0.0% |
| Employees | 115 | 7.5% |
| Net Income | -$5.89M | -18.4% |
| EBITDA | -$4.85M | -3.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $38.22M | 77.2% |
| Accounts Receivable | $5.26M | 15.8% |
| Inventory | 6.6 | -6.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $35.40M | 1020.9% |
| Short Term Debt | $0.35M | -35.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -46.03% | -2.8% |
| Return On Invested Capital | -42.81% | 2.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.32M | -174.2% |
| Operating Free Cash Flow | -$3.12M | -160.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 14.63 | 12.93 | 16.71 | 31.37 | 194.17% |
| Price to Sales | 13.53 | 10.22 | 10.04 | 18.04 | 77.50% |
| Price to Tangible Book Value | 14.95 | 13.18 | 17.11 | 31.37 | 187.96% |
| Enterprise Value to EBITDA | -79.53 | -55.01 | -65.56 | -127.21 | 104.15% |
| Return on Equity | -81.2% | -76.2% | -85.7% | -103.1% | 50.87% |
| Total Debt | $3.57M | $3.44M | $35.46M | $35.75M | 867.65% |
No podcast episodes available.
CLPT earnings call for the period ending June 30, 2022.
CLPT earnings call for the period ending March 31, 2022.
CLPT earnings call for the period ending December 31, 2021.
CLPT earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
